Human Non-Small Cell Lung Cancer Cells Express a Type 2 Cytokine Pattern

Cancer Research

Volumn 55, Issue 17, 1995, Pages 3847-3853

  Huang, Min ^a   Wang, Jianyi ^a,a   Lee, Paul ^a   Sharma, Sherven ^a   Mao, Jenny T ^a   Meissner, Horst ^a   Dubinett, Steven M ^a   Uyemura, Koichi ^a   Modlin, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; HUMAN; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029124129     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. North, R. J., Awwad, J. M., and Dunn, P. The immune response to tumors. Transplant. Proc., 21: 575–577, 1989.
2. Prehn, R. T. Tumor immunogenicity: how far can it be pushed? Proc. Natl. Acad. Sci. USA, 90: 4332–4333, 1993.
3. Yamamura, M., Modlin, R. L., Ohmen, J. D., and Moy, R. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest., 91: 1005–1010, 1993.
4. Alleva, D. G., Burger, C. J., and Elgert, K. D. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-a production: role of tumor-derived IL-10, TGF-0 and prostaglandin E2. J. Immunol., 755; 1674–1678, 1994.
5. Takizawa, H., Ohtoshi, T., Ohta, K., Yamashita, N., Hirohata, S., Hirai, K., Hiramatsu, K., and Ito, K. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res., 53: 4175–4181, 1993.
6. Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., and Strieter, R. M. Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med., 179: 1409–1415, 1994.
7. Wang, J., Huang, M., and Dubinett, S. M. Autocrine production of interleukin-8 decreases lung cancer proliferation and augments lymphocyte-tumor adhesion. J. Immunol., 150: 89, 1993.
8. Siegfried, J. M., and Owens, S. E. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line. Cancer Res., 48: 4976–4981, 1988.
9. Kelley, J. Transforming growth factorβ, In: C. Lenfant, and J. Kelley (eds.), Cytokines of the Lung, pp. 101–137. New York: Marcel Dekker, 1993.
10. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136: 2348–2357, 1986.
11. Romagnani, S. Human Thl and Th2 subsets: doubt no more. Immunol. Today, 12: 256–257, 1991.
12. Paul, W. E., and Seder, R. A. Lymphocyte responses and cytokines. Cell, 76: 241–251, 1994.
13. Romagnani, S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Intl. J. Clin. Lab. Res., 21: 152–158, 1991.
14. Lederer, J. A., Liou, J. S., Todd, M. D., Glimcher, L. H., and Lichtman, A. H. Regulation of cytokine gene expression in T helper cell subsets. J. Immunol., 152: 77–87, 1994.
15. Spagnoli, G. C., Juretic, A., Schultz-Thater, E., Dellabona, P., Filgueira, L., Horig, H., Zuber, M., Garotta, G., and Heberer, M. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity. Cell. Immunol., 146: 391–405, 1993.
16. Mosmann, T. R., and Moore, K. W. The role of IL-10 in crossregulation of Thl and Th2 responses. Immunol. Today, 12: A49-A53, 1991.
17. Minty, A., Chalon, P., Derocq, J. M., Dumont, X., Guillemot, J. C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., Minty, C., Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P., and Caput, D. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature (Lond.), 362: 248–250, 1993.
18. Kharkevitch, D. D., Seito, D., Balch, G. C., Maeda, T., Balch, C. M., and Itoh, K. Characterization of autologous-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int. J. Cancer, 58: 317–323, 1994.
19. Lee, P., Huang, M., Wang, J., Sherven, S., Beroiza, T., Ahmed, S., and Dubinett, S. M. Transforming growth factor-β specific antisense phosphorothioate oligonucleotides abrogate lung tumor associated immunosuppression. J. Immunol., 152: 3222, 1994.
20. Dubinett, S. M., Huang, M., Dhanani, S., Wang, J., and Beroiza, T. Down-regulation of macrophage transforming growth factor-β by interleukin-7. J. Immunol., 151: 6670–6680, 1993.
21. Huang, M., and Lindahl, R. Effects of hepatocarcinogenic initiators on aldehyde dehydrogenase gene expression in cultured rat hepatic cells. Carcinogenesis (Lond.), 11: 1059–1065, 1990.
22. Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U., and Murphy, K. M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity, 2: 665–675, 1995.
23. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production Thl cells. J. Immunol., 146: 3444–3451, 1991.
24. Enk, A., Angeloni, V., Uday, M., and Katz, S. Inhibition of Lagerhans cell antigen-presenting function by IL-10. J. Immunol., 151: 2390–2398, 1993.
25. Bluestone, J. A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity, 2: 555–559, 1995.
26. Van der Pouw kraan, T., Boeije, L., Smeenk, R., Wijdenes, J., and Aarden, L. Prostaglandin E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med., 181: 775–779, 1995.
27. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., and Kambayashi, T. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med., 180: 2365–2370, 1994.
28. Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R., and Bloom, B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (Washington DC), 254: 279–282, 1991.
29. Erard, F., Wild, M. T., Garcia-Sanz, J. A., and Le Gros, G. Switch of CD8 T cells to noncytolytic CD8-CD4 cells that make Th2 cytokines and helper B cells. Science (Washington DC), 260: 1802–1805, 1993.
30. Dubinett, S. M., and Kradin, R. L. Cytokine immunotherapy of non-small cell lung cancer. Reg. Immunol., 5: 232–242, 1993.
31. Doyle, A., Martin, W. J., Funa, K., Gazdar, A., Carney, D., Martin, S. E., Linnoila, I., Cuttitta, F., Mulshine, J., Bunn, P., and Minna, J. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J. Exp. Med., 161: 1135–1151, 1985.
32. Smith, D. R., Kunkel, S. L., Burdick, M. D., Wilke, C. A., Orringer, M. B., Whyte, R. I., and Strieter, R. M. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol., 145: 18–25, 1994.
33. Moody, T. W., Hida, T., Mulshine, J., Makheja, A., Zia, H., Ben-Av, P., and Hla, T. Cyclooxygenase inhibitors reduce prostagladin E2 and the growth of non-small cell lung cancer cells. Proc. Am. Assoc. Cancer Res., 36: 3577, 1995.
34. Phipps, R. P., Stein, S. H., and Roper, R. L. A new view of prostaglandin E regulation of the immune response. Immunol. Today, 12: 349–351, 1991.
35. Betz, M., and Fox, B. S. Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines. J. Immunol., 146: 108–113, 1991.
36. Kambayashi, T., Alexander, H. R., Fong, M., and Strassmann, G. Potential involvement of IL-10 in suppressing tumor-associated macrophages: colon-26-derived prostaglandin E2 inhibits TNF-a release via a mechanism involving IL-10. J. Immunol., 154: 3383–3390, 1995.
37. Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensverger, J., Apfel, R., Domes, R., Schlingensiepen, K., and Brysch, W. The effect of transforming growth factor-/32-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J. Neurosurg., 78: 944–951,1993.
38. Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., and Rowley, D. A. A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA, 87: 1486–1489, 1990.
39. Holland, G., Zlotnik, A. Interleukin-10 and cancer. Cancer Invest., 11: 751–758, 1993.
40. DeWaal-Malefyt, R., Abrams, J., Bennet, B., Figdor, C., and DeVries, J. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174: 1209–1220, 1991.
41. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol., 153: 811–816, 1994.
42. Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., and Granstein, R. D. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol., 154: 1280–1286, 1995.
43. DeWaal-Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and Vries, J. E. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-presenting human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class-11 major histocompatibility complex expression. J. Exp. Med., 174: 915–924, 1991.
44. Kazuyuki, T., Mostowski, H., and Tosato, G. Human interleukin-10 can directly inhibit T-cell growth. Blood, 81: 2964–2971, 1993.
45. Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., and Kiessling, R. Interleukin-10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J. Exp. Med., 180: 2371–2376, 1994.
46. Salazar-Onfray, F., Petersson, M., Franksson, L., Matsuda, M., Blankenstein, T., Karre, K., and Kiessling, R. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol., 154: 6291–6298, 1995.
47. Wang, L., Goillot, E., and Tepper, R. IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell. Immunol., 159: 152–169, 1994.
48. Blay, J. Y., Burdin, N., Rousset, F., Lenoir G., Biron, P., Philip Banchereau, J., and Favrot M. C. Serum interleukin-10 in non-Hodgkin′s lymphoma: a prognostic factor. Blood, 82: 2169–2174, 1993.
49. Benjamin, D., Knobloch, T. J., and Dayton, M. A. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt′s lymphoma constitutively secrete large quantities of interleukin-10. Blood, 80: 1289–1298, 1992.
50. Gotlieb, W. H., Abrams, J., Watson, J. M., Martinez-Maza, O., and Berek, J. S. Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancer. Cytokine, 4: 385–390, 1992.
51. Gastl, G. A., Abrans, J. S., Nanus, D. M., Oosterkanp, R., Silver, J., Liu, F., Chen, M., Albino, A. P., and Bander, N. H. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer, 55: 96–101,1993.
52. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., and Moser M. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol., 24: 605–610, 1994.
53. Paul, W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood, 77: 1859–1870, 1991.
54. Topp, M. S., Koenigsmann, M., Mire-Sluis, A., Oberberg, D., Eitelbach, F., Marschall, Z. V., Notter, M., Reufi, B., Stein, H., Thiel, E., and Berdel, W. E. Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood, 82: 2837–2844, 1993.
55. Morisaki, T., Uchiyama, A., Yuzuki, D., Essner, R., Morton, D. L., and Hoon D. S. B. Interleukin 4 regulates G, cell cycle progression in gastric carcinoma cells. Cancer Res., 54: 1113–1118,1994.
56. Newcom, S. R., Ansari, A. A., and Gu, L. Interleukin-4 is an autocrine growth factor secreted by the L-428 Reed-Sternberg cell. Blood, 79: 191–197, 1992.
57. Kawakami, Y., Rosenberg, S. A., and Lotze, M. T. Interleukin-4 promotes the growth of tumor infiltrating lymphocytes cytotoxic for human autologous melanoma. J. Exp. Med., 168: 2183–2186, 1989.
58. Essner, R., Rhoades, K., McBride, W. H., Morton, D. L., and Economou, J. S. IL-4 down-regulates IL-2 and TNF gene expression in human monocytes. J. Immunol., 142: 3857–3861, 1989.
59. Hart, P. H., Vitt, G. F., Burgess, D. R., Whitty, G. A., Piccoli D. S., and Hamilton, J. A. Potential antiinflammatory effects of IL-4: suppression of human monocyte TNF, IL-1 and PGE2. Proc. Natl. Acad. Sci. USA, 86: 3803–3807, 1989.
60. Standiford, T. J., Strieter, R. M., Chensue, S. W., Westwick, J., Kasahara, K., and Kunkel, S. L. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol., 145: 1435–1439, 1990.
61. Swisher, S. G., Economou, J. S., Holmes, E. C., and Golub, S. H. TNF-a and IFN-7 reverse IL-4 inhibition of lymphokine-activated killer cell function. Cell. Immunol., 128: 450–461, 1990.
62. Swain, S., Weinberg, A., English, M., and Huston, G. IL-4 directs the development of Th2-like helper effectors. J. Immunol., 145: 3796–3806, 1990.
63. Kopf, M., Le Gros, G., Nachmann, M., Lamers, M., Bluethmann, H., and Kohler, G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature (Lond.), 362: 245–248, 1993.
64. De Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., and De Vries, J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by 7-IFN or IL-10. J. Immunol., 151: 6370–6381, 1993.
65. Kriiger-Krasagakes, S., Li, W., Richter, G., Diamantstein, T., and Blankenstein, T. Eosinophils infiltrating interleukin-5 gene-transfected tumors do not suppress tumor growth. Eur. J. Immunol., 23: 992–995, 1993.
66. Dubinett, S. M., Huang, M., Dhanani, S., Economou, J. S., Wang, J., Lee, P., Sharma, S., Dougherty, G. J., and McBride, W. H. Down-regulation of murine fibrosarcoma transforming growth factor-01 expression by interleukin-7. J. Natl. Cancer Inst., 87: 593–597, 1995.